仁度生物
(688193)
| 流通市值：20.91亿 | | | 总市值：20.91亿 |
| 流通股本：4006.99万 | | | 总股本：4006.99万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 79,437,446.03 | 42,078,944.06 | 161,942,569.09 | 119,154,895.95 |
| 营业总成本 | 79,157,307.6 | 40,002,823.79 | 180,039,662.39 | 131,604,403.33 |
| 其他经营收益 | | | | |
| 营业利润 | 10,638,639.93 | 5,774,647.3 | 10,424,032.94 | 7,527,164.82 |
| 利润总额 | 10,326,604.54 | 5,470,304.22 | 10,219,043.53 | 7,341,900.33 |
| 净利润 | 9,575,519.87 | 4,995,403.92 | 10,087,386.2 | 7,013,721.57 |
| 每股收益 | | | | |
| 其他综合收益 | -1,025,542.49 | -521,780.89 | -812,996.32 | -428,869.26 |
| 综合收益总额 | 8,549,977.38 | 4,473,623.03 | 9,274,389.88 | 6,584,852.31 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 857,954,828.36 | 889,611,169.07 | 890,658,340.93 | 891,266,334.15 |
| 非流动资产: | | | | |
| 非流动资产合计 | 90,536,652.37 | 94,412,012.53 | 99,510,995.67 | 98,910,296.62 |
| 资产总计 | 948,491,480.73 | 984,023,181.6 | 990,169,336.6 | 990,176,630.77 |
| 流动负债: | | | | |
| 流动负债合计 | 57,441,580.84 | 59,414,657.11 | 68,971,897.22 | 64,223,338.56 |
| 非流动负债: | | | | |
| 非流动负债合计 | 6,981,420.91 | 6,031,682.84 | 7,287,945.74 | 7,597,053.71 |
| 负债合计 | 64,423,001.75 | 65,446,339.95 | 76,259,842.96 | 71,820,392.27 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 884,068,478.98 | 918,576,841.65 | 913,909,493.64 | 918,356,238.5 |
| 股东权益合计 | 884,068,478.98 | 918,576,841.65 | 913,909,493.64 | 918,356,238.5 |
| 负债和股东权益合计 | 948,491,480.73 | 984,023,181.6 | 990,169,336.6 | 990,176,630.77 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 89,978,214.04 | 42,882,909.57 | 207,288,260.43 | 139,838,591.34 |
| 经营活动现金流出小计 | 92,033,154.91 | 53,009,202.13 | 184,881,187.59 | 134,079,185.49 |
| 经营活动产生的现金流量净额 | -2,054,940.87 | -10,126,292.56 | 22,407,072.84 | 5,759,405.85 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,106,964,945.94 | 357,546,894.73 | 2,074,275,973.04 | 1,398,794,424.72 |
| 投资活动现金流出小计 | 1,025,000,000 | 350,000,000 | 2,250,074,497.89 | 1,515,470,809.31 |
| 投资活动产生的现金流量净额 | 81,964,945.94 | 7,546,894.73 | -175,798,524.85 | -116,676,384.59 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 2,627,112 | 2,692,368 |
| 筹资活动现金流出小计 | 40,091,608.94 | 925,389.14 | 12,167,465.68 | 5,999,729.95 |
| 筹资活动产生的现金流量净额 | -40,091,608.94 | -925,389.14 | -9,540,353.68 | -3,307,361.95 |
| 汇率变动对现金及现金等价物的影响 | -288,543.81 | -154,945.64 | -1,211,864.5 | 847,065.72 |
| 现金及现金等价物净增加额 | 39,529,852.32 | -3,659,732.6 | -164,143,670.19 | -113,377,274.97 |
| 期末现金及现金等价物余额 | 136,964,167.95 | 93,774,583.03 | 97,434,315.63 | 148,200,710.85 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 39,529,852.32 | - | -164,143,670.19 | - |